Patents by Inventor Luis Tomas

Luis Tomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10196586
    Abstract: Disclosed is a process for producing a composition involving: (a) distilling fish oil in a vacuum distillation column to obtain a first residue and first distillate, and (b) distilling the first distillate in a vacuum distillation column to obtain a second distillate and a second residue that includes a composition containing cholesterol, eicosapentaenoic acid, and docosahexaenoic acid. Also disclosed is a process for producing a composition involving: (a) distilling fish oil in a vacuum distillation column to obtain a first residue and first distillate, (b) distilling the first distillate in a vacuum distillation column to obtain a second distillate and second residue containing cholesterol, (c) esterifying the second residue to obtain a mixture containing cholesterol esters, and (d) distilling the mixture in a vacuum distillation column to obtain a third distillate and a third residue that includes a composition containing cholesterol esters of eicosapentaenoic acid and docosahexaenoic acid.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: February 5, 2019
    Assignee: GOLDEN OMEGA S.A.
    Inventors: Julio César Meza Almendra, José Luis Lopez Castillo, Pablo Napolitano Feito, Gustavo Adolfo Dorlhiac Silva, Luis Tomás Pincheira Varas, Alejandro Markovits Rojas
  • Patent number: 10190074
    Abstract: Disclosed is a process for producing a cholesterol concentrate including the steps of (a) distilling a fish oil having no more than 2% free fatty acids in an admixture with an auxiliary fluid in a vacuum distillation column to obtain a first distillate and a first residue; and (b) distilling the first distillate in a vacuum distillation column to obtain a second distillate and a second residue, wherein the second residue includes the cholesterol concentrate.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: January 29, 2019
    Assignee: GOLDEN OMEGA S.A.
    Inventors: Julio César Meza Almendra, José Luis Lopez Castillo, Pablo Napolitano Feito, Gustavo Adolfo Dorlhiac Silva, Luis Tomás Pincheira Varas, Alejandro Markovits Rojas
  • Publication number: 20070042718
    Abstract: Outer loop power control (OLPC) method and apparatus for mobile communications systems which allow rapid adjustment of the target desired signal to interference ratio (SIRtarget) satisfying a target block error rate (BLERtarget). Specifically, the outer loop power control method proposed herein is termed “Outage-Based OLPC” and establishes that the target desired signal to interference ratio (SIRtarget) is given as the sum of two components: the first component (SIRoutage-tgt) is calculated by means of a dynamic adjusting function, for example, a neural network which makes a quality criterion based on outage probabilities correspond with one based on the target block error rate (BLERtarget), taking as input the fading margins associated with the different outage probabilities considered; the other component (SIRBLER-tgt) is that which acts to correct the possible deviations in the target block error rate (BLERtarget) due to the non-ideal behaviour of the previous component (SIRoutage-tgt).
    Type: Application
    Filed: December 1, 2005
    Publication date: February 22, 2007
    Inventors: Alfonso Camacho, Alvaro Medrano, Miguel Carmona, Luis Tomas, Jose Hernando Rabanos
  • Patent number: 6905835
    Abstract: A non-instrumental assay for the diagnosis of celiac disease based on the general immunochromatographic assay principles. The assay is rapid and simple and allows the reliable detection of anti transglutaminase antibodies, of both IgA and IgG isotype, in samples of human serum, plasma or blood, using as tracer the antigen transglutaminase conjugated to a colored substance, like colloidal gold or colored latex particles. The conjugated antigen is deposited onto an inert fibrous support, from where it can be released by a liquid sample. The antibodies in the sample react with the conjugated antigen developing an immunocomplex that migrates through a carrier membrane, like nitrocellulose or nylon with a pore size that allows a laminar flow of the reagents, until it reacts with the same antigen transglutaminase immobilized onto a reactive zone of the membrane. As a consequence of this reaction the immunocomplex will be trapped in the reaction site and a colored signal will be seen.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: June 14, 2005
    Assignee: Centro De Ingenieria Genetica Y Biotecnologia CIGB
    Inventors: Luis Tomás Sorell Gómez, Boris Ernesto Acevedo Castro
  • Publication number: 20020006633
    Abstract: A non-instrumental assay for the diagnosis of celiac disease based on the general immunochromatographic assay principles. The assay is rapid and simple and allows the reliable detection of anti transglutaminase antibodies, of both IgA and IgG isotype, in samples of human serum, plasma or blood, using as tracer the antigen transglutaminase conjugated to a colored substance, like colloidal gold or colored latex particles. The conjugated antigen is deposited onto an inert fibrous support, from where it can be released by a liquid sample. The antibodies in the sample react with the conjugated antigen developing an immunocomplex that migrates through a carrier membrane, like nitrocellulose or nylon with a pore size that allows a laminar flow of the reagents, until it reacts with the same antigen transglutaminase immobilized onto a reactive zone of the membrane. As a consequence of this reaction the immunocomplex will be trapped in the reaction site and a colored signal will be seen.
    Type: Application
    Filed: May 25, 2001
    Publication date: January 17, 2002
    Inventors: Luis Tomas Sorell Gomez, Boris Ernesto Acevedo Castro